The New Age of Alzheimer’s

Advances in testing and treatment are galvanizing progress. Healthcare systems must also transform

Advances in early detection and treatment have galvanized scientists and given hope to patients

Most caregivers of people with Alzheimer’s find themselves behaving in ways they know are counterproductive. The disease affects their brains, too

A new model of Alzheimer’s predicts a staggering economic burden and justifies substantial investments in research, testing, treatments and public-health outreach

Genomics at a global scale could identify environmental causes, reveal disease-related mutations, and point the way to new therapeutic strategies

Amyloid immunotherapies took 20 years to reach the clinic. Scientists are testing new types of therapies they hope could deliver stronger benefits and fewer side effects

Gates talks about his own experience as a caregiver and all he is doing to fight this disease

A century after its discovery, scientists are beginning to grasp the complex biology of  Alzheimer’s. Now the race is on to develop new tests and treatments

Scientists are investigating a strategy of “secondary prevention,” in which drugs given early on stave off cognitive decline

Genes and age play a big role in susceptibility to the disease, but choices make a difference, too

If Alzheimer’s tests become accurate enough to reliably diagnose the disease, they could usher in a new era of preventive medicine

Healthcare systems must revamp their approach to deliver new tests and treatments to all the people who need them

As the first effective Alzheimer’s drugs are adopted, companies are racing to bring accurate screening tests to market

The optic nerve is a link to the brain—and potentially to Alzheimer’s diagnosis

The latest neuroscience tracks where the disease begins and how it progresses

Community-based programs are working to reverse decades of underrepresentation by building trust among clinicians, researchers and everyday people

In Volta Redonda, Brazil, gentle sleight of hand protects ‘patrons’ with dementia from the late-afternoon stress of sundown syndrome

Scotland is putting in place the infrastructure for preventing Alzheimer’s

Community leaders in Kenya are building awareness and empathy by bringing caregivers together to share their experiences

In Japan, where more than 90,000 people are 100 years or older, clinicians are advocating lifestyle habits that reduce the risk of Alzheimer’s

In Armenia, clinicians travel the countryside in a minivan, offering tests for Alzheimer’s

Dementia is poised to take off as the world ages, and the burden will be heavier in unexpected places

Reflections on a long-awaited Alzheimer’s forum